Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

TScan cuts 75% of workforce while shifting focus to solid tumor program

Summary by BioSpace
TScan Therapeutics is looking for strategic partnerships for its heme and autoimmune programs while working to advance two in vivo T cell therapy candidates into investigational new drug–enabling studies.

2 Articles

European Medical JournalEuropean Medical Journal

ArsenalBio and TScan cut jobs to focus on in vivo

ArsenalBio and TScan reduce their workforces in order to focus on therapies that work by engineering patients' cells inside the body.

Read Full Article
BioSpaceBioSpace

TScan cuts 75% of workforce while shifting focus to solid tumor program

TScan Therapeutics is looking for strategic partnerships for its heme and autoimmune programs while working to advance two in vivo T cell therapy candidates into investigational new drug–enabling studies.

·West Des Moines, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BioSpace broke the news in West Des Moines, United States on Thursday, September 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal